"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT05712642","A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity",,"Completed","No Results Available","Retinopathy of Prematurity","Drug: Intravitreal Bevacizumab","Change in the serum systemic VEGF pre- and post- intravitreal injection of bevacizumab in both groups.|The number of infants without need for rescue therapy until 60 weeks of postmenstrual age after initial treatment.|Occurrence of any adverse events from intravitreal-injection","Cairo University","All","28 Weeks to 40 Weeks   (Child)","Phase 3","19","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","MD-108-2019","February 1, 2020","December 30, 2020","January 28, 2021","February 3, 2023",,"February 3, 2023","Faculty of Medicine Cairo University, Cairo, Egypt",,"https://ClinicalTrials.gov/show/NCT05712642"
2,"NCT05712629","The Effect of Functional Bread Dadih",,"Completed","No Results Available","Weight, Birth|Weight, Body","Other: Body weight and body height of pregnant women, Body mass index of pregnant women, Body weight of infant, and Body height of infant|Other: Bread with vla dadiah and bread with vla without dadiah","Body Weight Pregnant Woman Measurement|Body Height Pregnant Woman Measurement|Body Mass Index Pregnant Woman Measurement|Birth Weight of Infant Measurement|Birth Length of Infant Measurement|Characteristic of Woman Pregnancy","Andalas University|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia","Female","18 Years to 45 Years   (Adult)","Not Applicable","88","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","HL","April 12, 2022","September 20, 2022","December 20, 2022","February 3, 2023",,"February 3, 2023","Universitas Andalas, Padang, West Sumatera, Indonesia","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/29/NCT05712629/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT05712629"
3,"NCT05712499","Mindfulness-based Psychoeducation and Defense Mechanisms, Mindful Awareness",,"Completed","No Results Available","Mindfulness|Psychoeducation|Defense Mechanisms|Awareness","Behavioral: mindfulness-based psychoeducation program|Behavioral: ongoing life","Change of defense mechanisms level after 10 weeks.|Change of mindful awareness level after 4 weeks.","Agri Ibrahim Cecen University","All","18 Years to 24 Years   (Adult)","Not Applicable","72","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","AICU-SBF-HB-BDG-01","March 8, 2021","March 8, 2021","May 17, 2021","February 3, 2023",,"February 3, 2023","Agri Ibrahim Cecen Universty /Faculty of Health Sciences, Ağrı, Central, Turkey",,"https://ClinicalTrials.gov/show/NCT05712499"
4,"NCT05712148","Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa",,"Completed","No Results Available","Retinitis Pigmentosa|Stem Cell Transplant","Biological: Stem cell implantation","Change in visual acuity after stem cell implantation in Retinitis Pigmentosa|Change in microperimetric evaluation after stem cell implantation in Retinitis Pigmentosa|Change in electrophysiological testing after stem cell implantation in Retinitis Pigmentosa","Acibadem University","All","Child, Adult, Older Adult","Phase 1|Phase 2","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","56733164/203 E.3858","October 11, 2019","January 30, 2022","June 14, 2022","February 3, 2023",,"February 3, 2023","Acıbadem University, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT05712148"
5,"NCT05712122","Stellatar Ganglione Blockage for Ventricular Arrhytmias",,"Completed","No Results Available","Cardiac Arrhythmia","Procedure: stellate block","ventricular arrhythmia numbers|ICD shock requirement","Adana City Training and Research Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","125-85","January 1, 2021","March 24, 2022","March 24, 2022","February 3, 2023",,"February 3, 2023","AdanaCityTRH, Adana, Yuregir, Turkey","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/22/NCT05712122/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT05712122"
6,"NCT05712031","Combined Tooth-implant Supported Prostheses","CTISP","Completed","No Results Available","Dental Implant|Short Dental Implant","Procedure: Insertion of 1 Nucleoss T4 dental implants in posterior mandible|Procedure: Insertion of 1 Nucleoss T5 dental implants in posterior mandible|Procedure: Insertion of 2 Nucleoss T4 dental implants posterior mandible","Marginal bone loss|Modified gingival index|Plaque index","ORHUN EKREN|Cukurova University","All","37 Years to 73 Years   (Adult, Older Adult)","Not Applicable","78","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Orhun ekren","July 3, 2015","June 6, 2022","September 9, 2022","February 3, 2023",,"February 3, 2023",,,"https://ClinicalTrials.gov/show/NCT05712031"
7,"NCT05711953","""PAIN LOTION"": Prospective Pre-market, Interventional, Single Arm Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Patiens With Stiffness and Pain.",,"Completed","No Results Available","Pain|Stiffness, Muscle","Other: Egyfil Pain Lotion","Muscle Stiffness, measured by Numerical Rating Scale (NRS)|Pain, measured by Numerical Rating Scale (NRS)|To evaluate the safety and tolerability of Pain Lotion when topically applied.","Contrad Swiss SA","All","18 Years to 60 Years   (Adult)","Not Applicable","26","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CTD-SW PAIN LOTION 2021","June 12, 2021","July 20, 2021","July 20, 2021","February 3, 2023",,"February 3, 2023","Stefano Picotti, Cardano Al Campo, Varese, Italy",,"https://ClinicalTrials.gov/show/NCT05711953"
8,"NCT05711875","The Effects of Using Virtual Reality Glasses During the Non-Stress Test",,"Completed","No Results Available","Pregnancy Related","Other: Virtual Reality (VR) glasses","Anxiety scores|Distress scores|Fetal Well-Being scores","Inonu University","Female","15 Years to 49 Years   (Child, Adult)","Not Applicable","71","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","2021/2302","October 15, 2021","December 21, 2021","February 1, 2022","February 3, 2023",,"February 3, 2023","Inonu University, Malatya, Turkey",,"https://ClinicalTrials.gov/show/NCT05711875"
9,"NCT05711810","Medicine-induced Cardiac Hemodialysis on COVID-19",,"Completed","No Results Available","Severe Acute Respiratory Syndrome-related Coronavirus|Renal Dialysis|Vaccines|Myocarditis Allergic|Infection Viral","Drug: Nifedipine 30 MG|Diagnostic Test: Kangzhu BPCB0A-3A|Behavioral: Low Mobility|Drug: Enalapril Maleate 10Mg Tab|Drug: Lansoprazole 30Mg Ec Cap|Drug: Metoprolol Succinate|Dietary Supplement: Coenzyme Q10|Dietary Supplement: d-alpha tocopherol acetate|Dietary Supplement: Omega-3|Drug: Duloxetine Hydrochloride 20 MG Oral Capsule, Delayed Release|Drug: Superoxide Dismutase","Heart Rate|Electrocardiogram|Platelet Distribution|Mean Platelet Volume|Eosinophil Absolute Number|Basophil Absolute Number|Cardiac Enzymes","Yang I. Pachankis|Pachankis, Yang I., M.D.","All","Child, Adult, Older Adult","Phase 4","1","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","SARSCoVVaxPoison","January 2, 2023","January 10, 2023","January 12, 2023","February 3, 2023",,"February 3, 2023","Residential Address, Chongqing, Chongqing, China",,"https://ClinicalTrials.gov/show/NCT05711810"
10,"NCT05711589","Zero-fluoroscopic Cryoballoon Ablation",,"Completed","No Results Available","Atrial Fibrillation Paroxysmal","Procedure: CBA was performed under intracardiac echocardiography guidance without fluoroscopy|Procedure: cryoablation (CBA) was performed under fluoroscopic guidance","Radiation exposure time|Radiation exposure dose|acute success rate|Recurrence rate of atrial tachyarrhythmias|Procedure time","Pusan National University Hospital","All","19 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","HALLYM 2019-04-025-001","January 1, 2020","June 30, 2022","December 31, 2022","February 3, 2023",,"February 3, 2023","Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT05711589"
11,"NCT05711472","The Effect of Birth Ball Exercise on Labor Pain, Delivery Duration, Birth Comfort, and Birth Satisfaction","BB","Completed","No Results Available","Childbirth Problems|Labor Pain|Birth Disorder","Other: birth ball exercise","Personal information form before intervention|Evaluation of birth|Evaluation of labor pain|Evaluation of Childbirth Comfort Questionnaire|Birth results information|Evaluation of Childbirth Satisfaction","Selcuk University","Female","18 Years to 45 Years   (Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","2020/1924","November 1, 2021","April 1, 2022","September 23, 2022","February 3, 2023",,"February 3, 2023","Selcuk University, Konya, Turkey",,"https://ClinicalTrials.gov/show/NCT05711472"
12,"NCT05711420","Comparison of the Effects of the Education Given to Nursing Students by Gamification Method and Flipped Learning Method on the Level of Participation, Attitude, Interest and Motivation",,"Completed","No Results Available","Educational Problems","Behavioral: Gamification method group|Behavioral: Flipped learning group","Teaching Material Motivation Scale|Student Interest Scale|Attitude Scale Towards Learning|Class participation","Sakarya University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","SakaryaU-metinyildiz-002","October 18, 2022","January 1, 2023","January 15, 2023","February 3, 2023",,"February 3, 2023","Sakarya University, Sakarya, Turkey",,"https://ClinicalTrials.gov/show/NCT05711420"
13,"NCT05711368","Effect of Distress Tolerance Training on Problematic Internet Use and Psychological Wellbeing Among Faculty Nursing Students",,"Completed","No Results Available","Nurse's Role","Behavioral: Distress tolerance training","The Problematic Internet Use Questionnaire (PIU)|Ryff psychological well being scale (PWBS)","Alexandria University","All","18 Years to 30 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB00013620/9/2022/48","September 1, 2022","January 1, 2023","January 15, 2023","February 3, 2023",,"February 3, 2023","Faculty of Nursing, Alexandria, Egypt",,"https://ClinicalTrials.gov/show/NCT05711368"
14,"NCT05711355","the Effects of Platelet-Rich Plasma on Postoperative Complications After Meningomyelocele",,"Completed","No Results Available","Meningomyelocele/Spina Bifida","Procedure: Use of Platelet-Rich Plasma after meningomyelocele sac repair|Procedure: meningomyelocele sac repair","Skin Dehicense Occurrence|Partial Skin Necrosis Occurrence|CSF Leak Occurrence|Local Infection Occurrence|Hydrocephalus Occurrence","Yuzuncu Yıl University","All","1 Day to 1 Month   (Child)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","YuzuncuYıl1","January 15, 2022","November 15, 2022","December 15, 2022","February 3, 2023",,"February 3, 2023","Van Yuzuncu Yıl Unıversty, Van, Turkey",,"https://ClinicalTrials.gov/show/NCT05711355"
15,"NCT05711303","Study to Investigate the Effect of Superba Boost on the Skin",,"Completed","No Results Available","Trans-epidermal Water Loss","Dietary Supplement: Superba Boost","To determine the effect of 12 weeks daily consumption of Superba Boost as compared to placebo on reduction in Trans-Epidermal Water-Loss (TEWL).|To determine the effect of daily consumption of Superba Boost as compared to placebo on the reduction of Trans-epidermal water loss (TEWL),|To assess the effect of daily consumption of Superba Boost as compared to placebo on changes in skin hydration|To assess the effect of daily consumption of Superba Boost as compared to placebo on changes in skin firmness (6 weeks)|To assess the effect of daily consumption of Superba Boost as compared to placebo on changes in skin firmness|To assess the effect of daily consumption of Superba Boost as compared to placebo on changes on subjective evaluation|To assess the effect of daily consumption of Superba Boost as compared to placebo on changes on Omega-3 index","Atlantia Food Clinical Trials","All","20 Years to 50 Years   (Adult)","Not Applicable","70","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Basic Science","AFCRO-097","March 13, 2019","August 12, 2019","December 20, 2019","February 3, 2023",,"February 3, 2023","Atlantia Food Clinical Trials, Cork, Munster, Ireland",,"https://ClinicalTrials.gov/show/NCT05711303"
16,"NCT05711277","The Taste and Acceptability of a High Protein Ice Cream Compared With Hospital Milkshake Nutritional Supplement",,"Completed","No Results Available","Femoral Fragility Fractures|Malnutrition","Dietary Supplement: Standard milkshake ONS (Fortisip Compact Protein)|Dietary Supplement: High protein, fortified, ice cream","Evaluation of acceptability by questionnaire (taste, texture, aroma, consistency etc).|Evaluation of product preference|Evaluation of compliance|Attitudes towards long term use of milkshake ONS and N-ICE CREAM by questionnaire|Feasibility of having N-ICE CREAM at home","Nottingham University Hospitals NHS Trust","All","65 Years and older   (Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","22HC002","June 20, 2022","September 1, 2022","September 1, 2022","February 2, 2023",,"February 2, 2023","Queens Medical Centre, Nottingham, Nottinghamshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT05711277"
17,"NCT05711225","Transtheoretic Model, Postpartum Smoking Relapse, Smoking Cessation Intervention",,"Completed","No Results Available","Postpartum Smoking Relapse","Behavioral: smoking cessation intervention given according to the web-based transtheoretic model during pregnancy on postpartum smoking relapse.","Measure 1- The Fagerström Test for Nicotine Dependence|Measure 2- Behavior Change Process Scale|Measure 3-Self-Efficacy Scale/Encouraging Factors Scale|Measure 4-Decision Balance Scale","Semra YILMAZ|Adiyaman University","Female","Child, Adult, Older Adult","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","SYILMAZ","March 24, 2021","May 1, 2022","December 1, 2022","February 2, 2023",,"February 2, 2023","Semra YILMAZ, Merkez, Adiyaman, Turkey",,"https://ClinicalTrials.gov/show/NCT05711225"
18,"NCT05711069","Core Stabilization Programme on Kicking Velocity and Performance in Male Adolescent Football Players",,"Completed","No Results Available","Soccer|Core Stability|Sports Performance","Other: Core Stability Exercise Program|Other: Routine Football Training Program","Kicking Velocity Measurement|Run Speed Measurement|Agility Measurement","Hacettepe University","Male","12 Years to 14 Years   (Child)","Not Applicable","45","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","ETK00-2020-0243","October 1, 2021","November 29, 2021","December 15, 2021","February 2, 2023",,"February 2, 2023","Fizyo osteopati Fizik Tedavi ve Sağlıklı Yaşam Merkezi, Nicosia, Lefkoşa, Cyprus",,"https://ClinicalTrials.gov/show/NCT05711069"
19,"NCT05710939","Effect of Scapular Stabilization Exercise Training on Posture and Pain in Fibromyalgia Patients",,"Completed","No Results Available","Fibromyalgia|Exercise, Compulsive|Pain|Postural; Defect","Other: exercises","visual analog scale ( VAS)|tragus-to-wall distance|fibromyalgia impact scale|Nottingham Health Profile","Sanko University","All","18 Years to 60 Years   (Adult)","Not Applicable","59","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","HakanPolat","November 1, 2016","February 1, 2017","June 1, 2018","February 2, 2023",,"February 2, 2023",,,"https://ClinicalTrials.gov/show/NCT05710939"
20,"NCT05710458","Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter",,"Completed","No Results Available","Vitrectomy|Epiretinal Membrane|Macular Hole|Vitreous Hemorrhage|Retinal Detachment","Device: 25 gauge 20,000 cpm Hypervit Dual Blade|Device: 25 gauge 10,000 cpm Ultravit Vitrectomy Cutter","Duration of Core vitrectomy|Non-inferiority of intraoperative and postoperative complication","The University of Hong Kong","All","18 Years and older   (Adult, Older Adult)","Not Applicable","72","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","20K","July 1, 2021","October 12, 2022","November 30, 2022","February 2, 2023",,"February 2, 2023","Grantham Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT05710458"
21,"NCT05710094","Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds",,"Completed","No Results Available","Chronic Leg Ulcer|Venous Leg Ulcer","Drug: SoftOx Biofilm Eradicator (Groups 1 to 7)|Device: Sterile isotonic saline (Groups 1 to 4)","Nature, occurrence, and severity of adverse events (AEs)|Change from baseline in wound pain assessed by use of visual analogue scale (VAS).|Change from baseline in wound bacterial burden (number of colony-forming units per mL; CFU/mL)","SoftOx Solutions AS","All","18 Years and older   (Adult, Older Adult)","Phase 1","28","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","SBE-01","October 19, 2021","August 19, 2022","August 19, 2022","February 2, 2023",,"February 2, 2023","Bispebjerg University Hospital, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT05710094"
22,"NCT05710068","Effects of RF Microneedle on Photoaging Skin",,"Completed","No Results Available","Pigmentation|Pigmentation Disorder","Device: RF Microneedle|Drug: Combination cream","Change of modified melasma area severity index score|Change of lightness value","Ajou University School of Medicine","Female","20 Years and older   (Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","AJOUIRB-INT-2021-133","December 1, 2021","August 1, 2022","September 1, 2022","February 2, 2023",,"February 2, 2023","Ajou University Hospital, Suwon, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT05710068"
23,"NCT05709938","Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM",,"Completed","No Results Available","To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children","Drug: Glargine and regular insulin versus NPH and regular insulin","HbA1c|Hypoglycemia|Fasting blood sugar|Post-meal blood|Mid night blood glucose level","King Edward Medical University","All","3 Years to 18 Years   (Child, Adult)","Phase 4","68","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Glargine and regular insulin","November 1, 2019","January 5, 2021","April 20, 2021","February 2, 2023",,"February 2, 2023","Pediatric endocrine and diabetes section, Pediatric department, Mayo Hospital, Lahore, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05709938"
24,"NCT05709808","Kinesio-Taping and Ankle Instability in Recreational Runners",,"Completed","No Results Available","Ankle Instability","Other: Kinesio-taping|Other: exercises|Other: mixed kinesiotape plus exercises","postural stability|star excursion test","University of Hail","All","17 Years to 25 Years   (Child, Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","12911","April 30, 2021","July 30, 2021","September 30, 2021","February 2, 2023",,"February 2, 2023","University of Hail, Ha'il, Hail, Saudi Arabia",,"https://ClinicalTrials.gov/show/NCT05709808"
25,"NCT05709587","Impacts of Application of Virtual Reality on Gait and Balance for Stroke Patients",,"Completed","No Results Available","Stroke","Other: Virtual reality training","Walking pace|Walking endurance|Balance test|Activities-specific balance confidence scale","Kaohsiung Medical University Chung-Ho Memorial Hospital","All","40 Years to 80 Years   (Adult, Older Adult)","Not Applicable","17","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","KMUHIRB-F(I)-20190135","June 1, 2020","October 7, 2020","October 7, 2020","February 2, 2023",,"February 2, 2023","Kaohsiung Municipal Ta-Tung Hospital (operation under entrustment with Kaohsiung Medical University Hospital), Kaohsiung, Taiwan",,"https://ClinicalTrials.gov/show/NCT05709587"
26,"NCT05709236","Digital Versus Conventional Full-arch Implant Impression in Maxillary Screw- Retained Implant Prosthesis",,"Completed","No Results Available","Jaw, Edentulous","Device: Maxillary screw-retained prosthesis","Number of events of prosthodontic complications|Amount of marginal bone loss","Delta University for Science and Technology","All","56 Years to 70 Years   (Adult, Older Adult)","Not Applicable","28","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","FODMRC/2022/00103","January 5, 2020","May 10, 2022","August 10, 2022","February 2, 2023",,"February 2, 2023","Delta University for Science & Technology, Mansoura, Egypt",,"https://ClinicalTrials.gov/show/NCT05709236"
27,"NCT05709080","Effectiveness of Family-Professional Collaboration on Functional Goals Achievement of Children With Cerebral Palsy and Caregivers' Quality of Life and Burden",,"Completed","No Results Available","Cerebral Palsy|Collaborative Intervention Process|Functional Goals Achievement","Other: family-professional collaboration practice model","Goals Attainments Scale (assessing change of the goals achievement from base line data)|World health organization quality of life- Brief assessing change of the quality of life from base line data)|Zarit Burden Interview- Arabic Abridged version assessing change of the burden from base line data)","King Saud University","All","2 Years to 12 Years   (Child)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","IRB No.: 36-2020-IRB","December 1, 2020","November 30, 2021","November 30, 2021","February 1, 2023",,"February 1, 2023","King Saud University, Riyadh, Saudi Arabia",,"https://ClinicalTrials.gov/show/NCT05709080"
28,"NCT05708937","THE EFFECT OF COGNITIVE AWARENESS SUPPORT ON THE PSYCHOSOCIAL STATUS OF WOMEN TREATED FOR INFERTILITY",,"Completed","No Results Available","Infertility|Infertility, Female","Behavioral: Mindfulness based phone app","Personal Information Form|Cognitive Awareness Scale|Infertility Self-Efficacy Scale|Depression Anxiety Stress Short Scale (DASS 21)|Mobile Application Evaluation Results|Fertility Adjustment Scale","Maltepe University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","34","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","E-74555795-050.01.04-52289","May 21, 2021","December 16, 2021","September 20, 2022","February 1, 2023",,"February 1, 2023","Maltepe Üniversitesi, Istanbul, Maltepe, Turkey",,"https://ClinicalTrials.gov/show/NCT05708937"
29,"NCT05708690","Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery",,"Completed","No Results Available","Coronary Artery Disease|Valvular Heart Disease|Surgical Blood Loss","Drug: Tranexamic Acid 100 MG/ML|Drug: normal saline","Initial Postoperative bleeding|6-hour postoperative bleeding|24-hour postoperative bleeding|48-hour postoperative bleeding|Postoperative blood product transfusion","Indonesia University","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 4","132","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","TRACS|1706120543|1706120530","October 1, 2022","December 31, 2022","January 6, 2023","February 1, 2023",,"February 1, 2023","National Cardiovascular Center Harapan Kita, Jakarta, DKI Jakarta, Indonesia","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/90/NCT05708690/Prot_SAP_000.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/90/NCT05708690/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT05708690"
30,"NCT05708664","Precision Breast Conserving Surgery With Guidance.",,"Completed","No Results Available","Breast Cancer","Procedure: precision breast conserving surgery guided by wire guided localization combined with MDCT guided 3D reconstruction","The sum of located margin resection widths|The specimen diameter|the largest margin resection width|Operation time|Patients reported outcomes","The First Affiliated Hospital with Nanjing Medical University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","92","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PBCST","August 1, 2021","June 30, 2022","January 1, 2023","February 1, 2023",,"February 1, 2023","The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China",,"https://ClinicalTrials.gov/show/NCT05708664"
31,"NCT05708339","Adaptation of Conventional Versus Virtually Fabricated Ear Prosthesis in Patients With Auricular Defects",,"Completed","No Results Available","Ear Deformity External","Other: virtually fabricated ear prosthesis|Other: conventionally fabricated ear prosthesis","Prosthesis adaptation using Silicon replica measuring technique.","Fatima Elmougi|Cairo University","All","10 Years and older   (Child, Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","19115","December 20, 2019","May 12, 2021","August 15, 2021","February 1, 2023",,"February 1, 2023","Cairo University, Cairo, Egypt",,"https://ClinicalTrials.gov/show/NCT05708339"
32,"NCT05708313","Effects of 9-18 Weeks of Intensive Cardiac Rehabilitation After a Major Cardiovascular Event in Patients With CVD","AHH-ICR","Completed","No Results Available","Cardiovascular Diseases|Lifestyle Risk Reduction","Behavioral: lifestyle modification","Serum Lipid|Body Mass Index|Resting Blood Pressure|Hemoglobin A1c|Dartmouth Coop quality of Life Questionnaire|Hospital Re-admission rate|Patient Health Questionnaire (PHQ9)|Duke Activity Index|6-minute walk test|Medication Changes|Perceived Exertion (RPE)|Resting Metabolic Rate|Diet intake","Arkansas Heart Hospital","All","65 Years to 85 Years   (Older Adult)","Not Applicable","198","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","AHH-002","September 20, 2019","June 27, 2021","June 27, 2021","February 1, 2023",,"February 1, 2023","Arkansas Heart Hospital-Clinic, Little Rock, Arkansas, United States",,"https://ClinicalTrials.gov/show/NCT05708313"
33,"NCT05708287","The Physiologic Effect of the Flow Generated by High Flow Nasal Cannula in Mild Respiratory Failure",,"Completed","No Results Available","Respiratory Failure","Device: HFNC","The effect of changing flow rates generated by HFNC on oxygenation parameters of 28 patients with mild respiratory failure|The effect of changing flow rates generated by HFNC on ventilation parameters of 28 patients with mild respiratory failure","Hadassah Medical Organization","All","18 Years to 120 Years   (Adult, Older Adult)","Not Applicable","28","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HMO-20-0260","August 1, 2020","December 31, 2020","December 31, 2020","February 1, 2023",,"February 1, 2023","Hadassah medical center, Jerusalem, Israel",,"https://ClinicalTrials.gov/show/NCT05708287"
34,"NCT05708196","Evaluation of β-tricalcium Phosphate/Calcium Sulfate Versus Allografts",,"Completed","No Results Available","Tooth Extraction","Other: Alloplast bone grafting material (EthOss, Ethoss Regeneration Ltd, Silsden, UK).|Other: Allograft bone grafting material.","Bone density measurement","Mansoura University","All","18 Years to 45 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M23011122","June 1, 2021","October 1, 2021","October 1, 2022","February 1, 2023",,"February 1, 2023","Heba Elsheikh, Mansoura, Egypt",,"https://ClinicalTrials.gov/show/NCT05708196"
35,"NCT05707624","The Effect of Video Education to the Febrile Child on the Knowledge, Attitudes and Behaviors of the Parents.",,"Completed","No Results Available","Fever|Child, Only|Approach-Approach Conflict|Parents","Other: video education|Other: the routine procedure","descriptive information form|Parent fever management scale","Eskisehir Osmangazi University","All","Child, Adult, Older Adult","Not Applicable","99","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Health Services Research","13895138840","July 14, 2020","December 25, 2022","December 26, 2022","February 1, 2023",,"February 1, 2023","Eskisehir Osmangazi University, Eskişehir, Tepebasi, Turkey",,"https://ClinicalTrials.gov/show/NCT05707624"
36,"NCT05707611","Acute Effects of Various Aerobic Exercise in Allergic Rhinitis.",,"Completed","No Results Available","Allergic Rhinitis","Other: Aerobic exercise include running cycling and swimming","Rhinitis symptom scores change|Cytokine in nasal secretion change|Pulmonary functions change|Respiratory muscle strength change|Peak nasal inspiratory flow change","Chulalongkorn University","All","18 Years to 45 Years   (Adult)","Not Applicable","15","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","EX PHYSIO SPSC 3","August 1, 2020","October 15, 2022","December 20, 2022","February 1, 2023",,"February 1, 2023","Faculty of Sports Science, Chulalongkorn University, Pathum Wan, Bangkok, Thailand",,"https://ClinicalTrials.gov/show/NCT05707611"
37,"NCT05707572","Morton's Neuroma: Manipulation Versus Steroid Injection",,"Completed","No Results Available","Morton Neuroma","Drug: methylprednisolone|Procedure: manual manipulation","Visual analogue pain scale|Algometric pressure threshold meter","Dundee Podiatry Clinic|Queen Margaret University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","62","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","PDN001|129586","September 2014","September 2018","September 30, 2019","February 1, 2023",,"February 1, 2023","Podiatry Department NHS Lothian, Edinburgh, Lothian, United Kingdom",,"https://ClinicalTrials.gov/show/NCT05707572"
38,"NCT05707104","Pilates and Plyometric Training on Physical Performance of Volleyball Players",,"Completed","No Results Available","Volleyball Players","Other: Pilates Exercises|Other: plyometrics exercises","Vertical jump test|Sit and reach test|30m sprint test|ILLINOIS AGILITY TEST","Riphah International University","All","18 Years to 30 Years   (Adult)","Not Applicable","38","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","REC/RCR & AHS/22/0430","January 8, 2022","October 1, 2022","October 15, 2022","January 31, 2023",,"January 31, 2023","Pakistan Sports Board, Lahore, PUnjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05707104"
39,"NCT05706792","Effectiveness of the Nordic Sensi Chair in the Treatment of Dementia Behavioral Disorders (NSC-DEMEN)","NSC-DEMEN","Completed","No Results Available","Dementia","Device: Nordic Sensi Chair","Change in behavioral and psychological symptoms of dementia measured by the Neuropsychiatric Inventory Nursing Home.|Change in agitation measured by the Cohen-Mansfield Agitation Inventory.|Change in depression measured by the Cornell Scale for Depression in Dementia.","Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","All","Child, Adult, Older Adult","Not Applicable","88","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","NSC-DEMEN Study","May 20, 2022","September 20, 2022","September 20, 2022","January 31, 2023",,"January 31, 2023","Instituto Andaluz de Neurociencia, Málaga, Spain",,"https://ClinicalTrials.gov/show/NCT05706792"
40,"NCT05706662","Dynamic Scaffold Versus Lichtenstein Open Hernioplasty.","DYSLOH","Completed","No Results Available","Inguinal Hernia","Procedure: inguinal hernia repair with mesh","early postoperative complications|patients clinical outcome|evaluation of quality of life during the postoperative period","University of Palermo","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","188","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","DySLOH","January 1, 2018","December 31, 2020","December 31, 2022","January 31, 2023",,"January 31, 2023","University of Palermo, Palermo, Italy",,"https://ClinicalTrials.gov/show/NCT05706662"
41,"NCT05706350","Plant Stanol Esters and Influenza Vaccination",,"Completed","No Results Available","Immune Response","Biological: Influenza vaccine|Dietary Supplement: Plant stanol soft chews (2g per day)|Dietary Supplement: Plant stanol soft chews (3g per day)|Dietary Supplement: Plant stanol soft chews (4g per day)|Dietary Supplement: Control soft chews","Vaccine specific IgM antibody titer|Vaccine specific IgG antibody titer|Immune parameters (1)|Immune parameters (2)|Leukocyte count|Leukocyte differential count|Fasted metabolism (1)|Fasted metabolism (2)|Fasted metabolism (3)|Anthropometry (1)|Anthropometry (2)|Anthropometry (3)|Anthropometry (4)|Anthropometry (5)|Diet|Liver elastography|Liver fat content|Diary outcomes (1)|Diary outcomes (2)","Maastricht University Medical Center|Raisio Nutrition Ltd.","All","59 Years and older   (Adult, Older Adult)","Not Applicable","137","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","METC 22-048","October 11, 2022","December 20, 2022","December 20, 2022","January 31, 2023",,"January 31, 2023","Maastricht University Medical Center, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT05706350"
42,"NCT05706246","Perioperative Hypersensitivity in Children",,"Completed","No Results Available","Drug Allergy","Diagnostic Test: diagnostics","Perioperative hypersensitivity frequency|Defining the culprit agent","Istanbul University - Cerrahpasa (IUC)","All","0 Years to 18 Years   (Child, Adult)","Not Applicable","29","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","HIPOP","June 30, 2020","June 30, 2021","June 28, 2022","January 31, 2023",,"January 31, 2023","Istanbul University-Cerrahpasa, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT05706246"
43,"NCT05706090","Effect of Neurostimulator Usage on Block Success",,"Completed","No Results Available","PATIENTS WITH UPPER EXTREMITY SURGERY","Drug: fentanyl will be added|Procedure: general anesthesia","The block success rate (ratio of successful blocks to all blocks)|Block application time|time to readiness for surgery|number of needle passes","Gaziosmanpasa Research and Education Hospital","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","Neurostimulator Usage","February 1, 2020","February 1, 2020","January 2, 2021","January 31, 2023",,"January 31, 2023","Gazoosmanpasa Education and Research Hospital, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT05706090"
44,"NCT05705713","First-day Computed Tomography: Does it Has a Role in the Assessment of Patients With Inhalation Lung Injury?",,"Completed","No Results Available","Inhalation Injury","Radiation: chest computed tomography (CT)","bronchial wall thickening (BWT)|Radiologist score","Menoufia University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","58","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","12/2022COM2","December 1, 2015","January 1, 2019","March 1, 2019","January 31, 2023",,"February 1, 2023",,,"https://ClinicalTrials.gov/show/NCT05705713"
45,"NCT05705622","The Effect of Nursing Education on Oral Mucositis in Bone Marrow Transplant Patients",,"Completed","No Results Available","Blood Stem Cell Transplant Failure|Oral Mucositis|Nurse's Role","Other: Oral mukositis nurse's education for patients","Patient Diagnosis Form|Mucositis Evaluation Form of the World Health Organization|Oral Mucositis Risk Assessment Scale in Hematology Patients|Oral Mucous Membrane Evaluation and Follow-up Form","Antalya Training and Research Hospital|Suleyman Demirel University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","64","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","2010","September 1, 2022","January 6, 2023","January 13, 2023","January 31, 2023",,"January 31, 2023","Süleyman Demirel Üniversitesi, Isparta, Turkey",,"https://ClinicalTrials.gov/show/NCT05705622"
46,"NCT05705609","The Effect of Mandala Art Therapy on Pregnant Women With Abnormal OGTT",,"Completed","No Results Available","Pregnancy Related","Other: Mandala art therapy","Anxiety scores|Mood scores","Inonu University","Female","15 Years to 49 Years   (Child, Adult)","Not Applicable","68","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","2022/3679","December 20, 2022","December 23, 2022","January 20, 2023","January 31, 2023",,"January 31, 2023","Inonu University, Malatya, Turkey",,"https://ClinicalTrials.gov/show/NCT05705609"
47,"NCT05705336","Clinical Trial Analyzing the Efficacy of Oral Administration of Tranexamic Acid in Spine Surgery.",,"Completed","No Results Available","Tranexamic Acid (TXA)|Prospective Study|Evidence-based Medicine|Randomized Controlled Trial","Drug: Tranexamic Acid Oral Product|Drug: Placebo pills","Total volume of blood loss","Alejandro Reyes Sánchez|National Institute of Rehabilitation, Mexico","All","40 Years to 70 Years   (Adult, Older Adult)","Phase 4","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","N0421","January 1, 2021","December 30, 2021","January 1, 2022","January 30, 2023",,"January 30, 2023","Alejandro Reyes Sánchez, Mexico City, Mexico",,"https://ClinicalTrials.gov/show/NCT05705336"
48,"NCT05704998","INVESTIGATION AND COMPARISON OF THE EFFECTS OF POSTURE EXERCISES ON DYSFUNCTION, POSTURE AND BALANCE IN INDIVIDUALS WITH POSTERIOR EDENTULOUS AND FULL-TOOTHED TEMPOROMANDIBULAR DISORDER",,"Completed","No Results Available","Temporomandibular Disorder","Other: Physiotherapy","Mandibular Range of Motion|Posture|Balance|Pain Score with Numeric Pain Rating Scale (NPRS)|Active Cervical Range of Motion|Beck Depression Inventory","Dokuz Eylul University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","26","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","DEU.HSI.MSc-2019970200","June 1, 2022","July 15, 2022","August 30, 2022","January 30, 2023",,"January 30, 2023","Dokuz Eylul University, Izmir, Turkey",,"https://ClinicalTrials.gov/show/NCT05704998"
49,"NCT05704608","Effects of Aerobic Training Program On Liver Functions",,"Completed","No Results Available","Liver Functions","Other: Aerobic training","Bilirubin-Total|Serum aspartate aminotransferase/serum glutamic-oxaloacetic transaminase (AST/SGOT)|Serum alanine transaminase/Serum Glutamic Pyruvic Transaminase (ALT/SGPT)|Alkaline Phosphatase|Protein-Total|Albumin|Globulin","King Saud University","Male","21 Years to 24 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","DN 4900 /FSS","September 1, 2021","July 14, 2022","November 30, 2022","January 30, 2023",,"January 30, 2023","King Saud University, Riyadh, Saudi Arabia",,"https://ClinicalTrials.gov/show/NCT05704608"
50,"NCT05704114","Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne",,"Completed","No Results Available","Acne Vulgaris|Post Inflammatory Hyperpigmentation|Post Inflammatory Pigmentation Change|Erythema|Skin Scarring","Drug: Tazarotene 0.045% Lotion","Reduction of postinflammatory erythema lesion count.|Reduction of postinflammatory hyperpigmentation lesion count.|Reduction of active acne lesion count|Patient perceived improvement through completion of a patient satisfaction survey","Dr. Emmy Graber|The Dermatology Institute of Boston","All","18 Years to 45 Years   (Adult)","Phase 4","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","DIB-0201","February 1, 2021","February 1, 2022","May 1, 2022","January 30, 2023",,"January 30, 2023","The Dermatology Institute of Boston, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT05704114"
51,"NCT05703906","Teleneurorehabilitation for the Continuity of Care Post-stroke: a Multicentric Pilot Study","TELEICTUS","Completed","No Results Available","Stroke","Behavioral: Telerehabilitation - VRRS Khymeia","Feasibility of telerehabilitation system|Change in measure of quality of life|Change in motor functions|Change in linguistic functions|Change in cognitive functions|Change in Independence (Activities of Daily Living)|Change in behavior (depression)|Change in caregiver burden|Satisfaction of the treatment","IRCCS San Camillo, Venezia, Italy|IRCCS Centro Neurolesi Bonino-Pulejo, Messina (IT)|Fondazione Don Carlo Gnocchi Onlus|IRCCS Fondazione Istituto Neurologico Casimiro Mondino, Pavia (IT)|IRCCS San Raffaele Roma|Istituto Clinico Humanitas","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","84","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2017.16","March 16, 2018","November 30, 2021","December 31, 2021","January 30, 2023",,"January 30, 2023","IRCCS San Camillo Hospital, Venice, Italy",,"https://ClinicalTrials.gov/show/NCT05703906"
52,"NCT05703867","Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration",,"Completed","No Results Available","Age-Related Macular Degeneration|Nonexudative Age-related Macular Degeneration","Device: Active microcurrent therapy","Mean logMAR BCVA|Proportion of improved, stable or worsened BCVA","Jarding, John, OD|Professor Timothy Jackson, King's College|i-Lumen Scientific, Inc.","All","50 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","404","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","OL101","January 1998","December 1999","December 1999","January 30, 2023",,"January 31, 2023",,,"https://ClinicalTrials.gov/show/NCT05703867"
53,"NCT05703776","Physical Exercise and Depressive Symptoms in Moderately or Severely Depressed Adults","EXIMOS","Completed","No Results Available","Depressive Symptoms","Behavioral: Nordic Walking","change in the intensity of depressive symptoms","Je Bouge Pour Mon Moral|University Grenoble Alps","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","JBPMM-1","January 19, 2022","April 15, 2022","May 1, 2022","January 30, 2023",,"January 30, 2023","association JBPMM, Nancy, France",,"https://ClinicalTrials.gov/show/NCT05703776"
54,"NCT05703529","Group-based Positive Psychotherapy in Psychological Resilience of Only-Child-Lost People",,"Completed","No Results Available","Resilience, Psychological|Bereavement|Mental Health","Behavioral: Positive Psychotherapy|Other: Usual Care","Change of psychological resilience|Change of depressive symptoms|Change of index of well-being|Change of Dehydroepiandrosterone (DHEA) in saliva|Change of Sleep Quality|Change of Social Avoidance and Social Distress","Central South University","All","49 Years and older   (Adult, Older Adult)","Not Applicable","68","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2015058","March 1, 2016","October 31, 2016","October 31, 2016","January 30, 2023",,"January 30, 2023",,,"https://ClinicalTrials.gov/show/NCT05703529"
55,"NCT05703477","Donor Microbiota of Fecal Microbiota Transplantation for CDI",,"Completed","No Results Available","Clostridium Difficile Infection|Fecal Microbiota Transplantation","Procedure: Fecal microbiota transplantation","changes of microbiota before and after FMT treatment","Shanghai 10th People's Hospital","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","FMTCDI","January 1, 2020","August 30, 2022","August 30, 2022","January 30, 2023",,"January 30, 2023","Shanghai Tenth People's Hospital, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT05703477"
56,"NCT05703438","The Effect of a Low-calorie Diet With Balanced Nutrition on Metabolic Syndrome",,"Completed","No Results Available","Metabolic Syndrome, Protection Against","Other: Nutritionally balanced low-calorie diet","Change from baseline body mass index at 8 weeks.|Change from baseline waist circumference at 8 weeks.|Change from baseline systolic and diastolic blood pressure at 8 weeks.|Change from baseline fat mass percentage at 8 weeks.|Change from baseline fasting blood sugar levels at 8 weeks.|Change from baseline lipid profile levels at 8 weeks.","Andalas University|Universitas Sumatera Utara|Hasanuddin University","All","Child, Adult, Older Adult","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RKI2022","August 5, 2022","December 4, 2022","December 4, 2022","January 30, 2023",,"February 2, 2023","Universitas Andalas, Padang, Sumatera Barat, Indonesia",,"https://ClinicalTrials.gov/show/NCT05703438"
57,"NCT05703308","Menstrual Blood Stem Cells in Poor Ovarian Responders",,"Completed","No Results Available","Poor Ovarian Response|Infertility, Female","Biological: Autologous Menstrual Blood Stem Cells","Spontaneous pregnancy rate|Pregnancy rate after ICSI|Hormone levels|Number of oocytes|Number of MII oocytes|Number of embryos|Number of high quality embryos number|Clinical pregnancy rate|Biochemical pregnancy rate|Live birth rate|Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]","Avicenna Research Institute","Female","25 Years to 45 Years   (Adult)","Phase 3","180","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","99008-1023","June 21, 2020","September 22, 2021","October 22, 2022","January 30, 2023",,"January 30, 2023","Avicenna Research Institute, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT05703308"
58,"NCT05703113","The Effect of the Education Given to Nursing Students With Web 2.0 Tools on the Level of Participation, Attitude, Interest and Motivation",,"Completed","No Results Available","Educational Problems","Behavioral: Web 2.0 tools","Teaching Material Motivation Scale|Student Interest Scale|Attitude Scale Towards Learning|Class participation","Sakarya University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","110","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","SakaryaU-metinyildiz-003","October 18, 2022","January 15, 2023","January 15, 2023","January 27, 2023",,"January 27, 2023","Sakarya University, Sakarya, Turkey",,"https://ClinicalTrials.gov/show/NCT05703113"
59,"NCT05703087","Positive Cueing in Knee Arthroplasty.",,"Completed","No Results Available","Osteoarthritis, Knee|Psychological Stress|Mental Stress","Behavioral: Positive cueing in the information video before a primary TKA","Feasibility outcome measure: acceptibility.|Feasibility outcome measure: rate of recruitment|Feasibility outcome measure: comprehensibility|Feasibility outcome measure:patients' feedback to the current protocol.","Leiden University Medical Center|Onze Lieve Vrouwe Gasthuis|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","WO 21.122","September 21, 2021","November 1, 2021","November 1, 2021","January 27, 2023",,"January 27, 2023","LUMC, Leiden, Netherlands",,"https://ClinicalTrials.gov/show/NCT05703087"
60,"NCT05702957","Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome",,"Completed","No Results Available","Polycystic Ovary Syndrome|Infertility","Drug: letrozole 2.5mg-7.5mg|Drug: Clomiphene Citrate 50mg-150mg","Pregnancy rate|ovulation rate|Live birth rate|Monofollicular development|Multifollicular development|Miscarraige|Adverse effects","Services Institute of Medical Sciences, Pakistan","Female","18 Years to 40 Years   (Adult)","Phase 2|Phase 3","220","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","IRB/2015/209/SIMS","September 2016","October 2019","December 2019","January 27, 2023",,"January 27, 2023","Services Institute of Medical sciences, Lahore, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05702957"
61,"NCT05702892","Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases",,"Completed","No Results Available","Periodontal Diseases","Diagnostic Test: ELISA","Evaluation of bone metabolism biomarkers in different periodontal conditions|Probing pocket depth|Gingival index|Plaque index","Necmettin Erbakan University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","Ummuhan.tekinatay","November 5, 2020","May 5, 2021","November 5, 2021","January 27, 2023",,"January 27, 2023","Necmettin Erbakan University, Konya, Turkey",,"https://ClinicalTrials.gov/show/NCT05702892"
62,"NCT05702697","The Efficacy of Focus Extracorporeal Shock Wave Therapy on Hamstring Tightness",,"Completed","No Results Available","Hamstring Tightness","Device: focus extracorporeal shock wave therapy|Behavioral: Home stretching program","Passive knee extension test|Back-saver sit-and-reach test (BSSR)|Sit and reach test (SRT)|Toe touch test (TT)","Mahidol University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","124","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","COA. MURA2020/1084","September 1, 2020","January 31, 2021","August 1, 2021","January 27, 2023",,"January 27, 2023","Physical medicine and rehabilitation, Bangkok, Thailand",,"https://ClinicalTrials.gov/show/NCT05702697"
63,"NCT05702632","TheraTogs Versus Reciprocal Electrical Stimulation on Children With Diplegic Cerebral Palsy: a Randomized Controlled Trial",,"Completed","No Results Available","Down Syndrome","Device: 1- Reciprocal electrical stimulation|Device: TheraTogs orthotic treatment|Procedure: traditional physical therapy program","postural stability","Cairo University","All","6 Years to 8 Years   (Child)","Not Applicable","15","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","Approaches","July 15, 2022","September 8, 2022","December 30, 2022","January 27, 2023",,"January 27, 2023","Cairo University, Giza, Eldoky, Egypt",,"https://ClinicalTrials.gov/show/NCT05702632"
64,"NCT05702606","Shock Wave Therapy for Management of Spasticity in Patients With Cerebral Palsy",,"Completed","No Results Available","Cerebral Palsy|Spasticity, Muscle|Extracorporeal Shock Wave Therapy","Other: Radial extracorporeal shock wave therapy (rESWT)","Change in passive range of movement and the stretching reflex in ankle dorsiflexion. Tardieu Scale|Change in goal attainment scale (GAS)|Pain secondary to spasticity assessed by the visual analog scale|Satisfaction with the therapy assessed by the visual analog scale|Adverse effects by Data collection notebook","Fundacio Aspace Catalunya","All","4 Years to 50 Years   (Child, Adult)","Not Applicable","73","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","ASP_Shock_MT","June 10, 2021","October 3, 2022","October 3, 2022","January 27, 2023",,"January 27, 2023","Fundació Aspace Catalunya, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT05702606"
65,"NCT05702372","Acute Glycemic Effects of Crackers Made by Different Flours",,"Completed","No Results Available","Potential Abnormality of Glucose Tolerance|Appetitive Behavior","Other: Glucose as reference food|Other: Cracker made by wheat flour|Other: Cracker made by rye flour|Other: Cracker made by sunflower flour","Capillary blood glucose responses|Subjective appetite ratings|Blood pressure","Agricultural University of Athens","All","18 Years to 55 Years   (Adult)","Not Applicable","11","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Investigator)|Primary Purpose: Other","HRBD 80/12.10.2022","September 19, 2022","January 19, 2023","January 19, 2023","January 27, 2023",,"January 27, 2023","Agricultural University of Athens, Athens, Greece",,"https://ClinicalTrials.gov/show/NCT05702372"
66,"NCT05702307","Determining the Glycemic Effects of Sunflower Pasta",,"Completed","No Results Available","Potential Abnormality of Glucose Tolerance|Appetitive Behavior","Other: Glucose as reference food|Other: Tagliatella control|Other: 5% sunflower tagliatella|Other: 16% sunflower tagliatella|Other: 16% sunflower penne|Other: 16% sunflower fusilli","Capillary blood glucose responses|Subjective appetite ratings|Blood pressure","Agricultural University of Athens","All","18 Years to 55 Years   (Adult)","Not Applicable","16","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Investigator)|Primary Purpose: Other","HRBD 60 23/06/2022","October 15, 2022","January 15, 2023","January 15, 2023","January 27, 2023",,"January 27, 2023","Agricultural University of Athens, Athens, Attica, Greece",,"https://ClinicalTrials.gov/show/NCT05702307"
67,"NCT05702190","Opium Tincture Against Chronic Diarrhea - Healthy",,"Completed","No Results Available","Chronic Diarrhea","Drug: Opium tincture|Drug: Placebo","Gastrointestinal transit|Colonic motility patterns|Bowel movement frequency|Stool consistency|Pupil diameter|General cognition|Reaction time|Short-term memory|Gastrointestinal symptoms|Constipation symptoms|Electroencephalography spectral analysis|Pain tolerance threshold|Conditioned pain modulation|Gastric half emptying time|Gastric contraction assessment|Small bowel motility assessment|Small bowel water content|Colon volume|Estimated gastrointestinal transit time","Asbjørn Mohr Drewes|Aalborg University Hospital","All","20 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","Dropizol_healthy|2020-004875-41","March 9, 2021","June 1, 2022","June 1, 2022","January 27, 2023",,"January 30, 2023","Aalborg University Hospital, Aalborg, Denmark",,"https://ClinicalTrials.gov/show/NCT05702190"
68,"NCT05702086","Making SPARX Fly in Nunavut: Pilot Testing an E-intervention for Boosting Resilience Against Youth Depression",,"Completed","No Results Available","Depressive Symptoms|Emotion Regulation","Other: SPARX (Smart, Positive, Active, Realistic, X-Factor thoughts)","""Centre for Epidemiologic Depression Scale - Revised""|""Hopelessness Scale for Children""|""Cognitive Emotion Regulation Questionnaire - Short""|""Child and Youth Resilience Measure - Short""","York University|Government of Nunavut|Qaujigiartiit Health Research Centre","All","13 Years to 18 Years   (Child, Adult)","Not Applicable","48","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","02 004 15N-M","September 8, 2014","April 22, 2015","April 22, 2015","January 27, 2023",,"January 31, 2023","York University, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05702086"
69,"NCT05702008","Social Media as an Information, Education and Communication Tool for Rabies Prevention: An Interventional Study",,"Completed","No Results Available","Rabies|Health Education|Public Health|Preventive Health Services","Other: Rabies Information Education and Communication Material","To measure the impact of a social media-based dissemination strategy on information dissemination and retention for rabies IEC material among preclinical medical students","Maulana Azad Medical College","All","Child, Adult, Older Adult","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","F.1/IEC/MAMC/90/02/2022/No.112","July 1, 2022","August 1, 2022","September 1, 2022","January 27, 2023",,"January 27, 2023","Maulana Azad Medical College, Delhi, India",,"https://ClinicalTrials.gov/show/NCT05702008"
70,"NCT05701943","Comparison of Home- vs. Gym-based Exercise Delivery Modes","UPSIDE DOWNS","Completed","No Results Available","Vascular Stiffness|Cardiorespiratory Fitness","Behavioral: Home-Based|Behavioral: Gym-Based","Change in Cardiorespiratory Fitness|Change in Arterial Stiffness|Change in Arterial Structure|Change in Body Mass Index|Change in Body Composition|Change in Waist Circumference","Egas Moniz - Cooperativa de Ensino Superior, CRL|Ginásio Clube Português|Faculdade de Motricidade Humana - Universidade de Lisboa|Universidade Europeia","All","18 Years to 55 Years   (Adult)","Not Applicable","17","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","UPSIDE DOWNS","November 2, 2020","July 30, 2021","July 30, 2021","January 27, 2023",,"January 27, 2023","Ginásio Clube Português, Lisboa, Portugal",,"https://ClinicalTrials.gov/show/NCT05701943"
71,"NCT05701683","IMPROVEMENT in ERADICATION of H-PYLORI INFECTION",,"Completed","No Results Available","Helicobacter Pylori Infection","Drug: Lactobacillus Reuteri Probiotic","Eradication rate","Liaquat National Hospital & Medical College","All","18 Years to 60 Years   (Adult)","Phase 4","195","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","0493-2019-LNH-ERC","November 15, 2019","November 20, 2021","December 31, 2022","January 27, 2023",,"January 27, 2023","Mehreen Akmal, Karachi, Sindh, Pakistan",,"https://ClinicalTrials.gov/show/NCT05701683"
72,"NCT05701202","Assessing the Impact of ""Super-whey"" vs. Isonitrogenous Whey on Muscle Protein Synthesis","ARLA-WHEY","Completed","No Results Available","Sarcopenia","Dietary Supplement: Super-Whey protein|Dietary Supplement: Isonitrogenous whey protein","Muscle protein fractional synthetic rate (postabsorptive)|Muscle protein fractional synthetic rate (postprandial)|Plasma amino acid concentrations","University of Nottingham","Male","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","ARLA-WHEY_PtA_CMMP","June 15, 2021","November 22, 2022","November 22, 2022","January 27, 2023",,"January 27, 2023","Centre of Ageing, Metabolism and Physiology, Derby, United Kingdom",,"https://ClinicalTrials.gov/show/NCT05701202"
73,"NCT05701124","Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity",,"Completed","No Results Available","Retina Disease|Retinopathy of Prematurity|Ranibizumab","Drug: Ranibizumab (0.25 mg/0.025 mL)","Number of eyes that achieved regression of plus disease or active neovessels achieved either by single or multiple injections|The number of eyes in which retinal vessels reach ora serrata (complete retinal vascularization)|The number of eyes that showed recurrent plus disease, recurrent neovascularization, reformation of a ridge|The number of eyes that needed late peripheral laser|The number of eyes progressing to stage 4 or 5 necessitating vitrectomy with/without lensectomy","Zagazig University|Cairo University","All","28 Days to 3 Months   (Child)","Phase 3","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","ZU-IRB#6269/22-7-2020","November 20, 2020","November 20, 2022","November 20, 2022","January 27, 2023",,"January 30, 2023","Zagazig University, Faculty of medicine, Zagazig, Egypt",,"https://ClinicalTrials.gov/show/NCT05701124"
74,"NCT05700851","Immuno-nutrition Supplementation in Haemodialysis",,"Completed","No Results Available","Chronic Kidney Disease Requiring Chronic Dialysis","Dietary Supplement: Immuno-nutrition supplement","Systemic inflammation|Haemoglobin and protein status|Creatinine|Urea, electrolytes, minerals and lipid profile.|Body mass index|Body lean mass|Body fat mass|Energy intake|Protein and fat intake|Muscle strength|Skin autofluorescence","University of Nottingham|University Hospitals of Derby and Burton NHS Foundation Trust","All","18 Years and older   (Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","21085|309937","September 27, 2022","December 9, 2022","December 9, 2022","January 26, 2023",,"January 26, 2023","Department of Renal Medicine, Royal Derby Hospital, Derby, Derbyshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT05700851"
75,"NCT05700578","Evaluation of a Novel Behavior Change Intervention for Posttraumatic Stress",,"Completed","No Results Available","PTSD","Behavioral: Safety Behavior Elimination for Traumatic Stress (SBETS)|Behavioral: Modifiable Behavior Intervention (MoBI)","PTSD Checklist for DSM-5 (PCL-5)|Posttraumatic Safety Behavior Questionnaire (PSBQ)","Florida State University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","STUDY00002835","February 27, 2022","November 14, 2022","November 14, 2022","January 26, 2023",,"January 26, 2023","Anxiety and Behavioral Health Clinic, Tallahassee, Florida, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/78/NCT05700578/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT05700578"
76,"NCT05700487","EFFECT ON QUALITY OF LIFE AFTER PROSTATECTOMY",,"Completed","No Results Available","PROSTATECTOMY|URINARY INCONTINENCE","Other: PELVIC FLOOR EXERCISES","Quality of life Scale(SF-36)|The Overactive Bladder (OAB-V8 )","TC Erciyes University","Male","40 Years to 75 Years   (Adult, Older Adult)","Not Applicable","33","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research","PROSTATK","August 1, 2019","October 30, 2020","April 29, 2021","January 26, 2023",,"January 27, 2023","ERciyes University, Kayseri, Turkey",,"https://ClinicalTrials.gov/show/NCT05700487"
77,"NCT05699798","The Aim of This Study is to Compare the Effects of Instrument-assisted Soft Tissue Mobilization (IASTM) and Extracorporeal Shock Wave Therapy (ESWT) Used in Myofascial Pain Syndrome (MPS) and to Determine Whether They Are Superior to Conservative Treatment (CT)",,"Completed","No Results Available","Myofascial Pain Syndrome","Other: Conservative Treatment (CT)|Other: Instrument-assisted Soft Tissue Mobilization (IASTM)|Other: Extracorporeal Shock Wave Therapy (ESWT)","Pain Intensity|Pressure Pain Threshold|Cervical Joint Range of Motion|Disability|Depression and Anxiety","Ankara University|Gazi University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","candeniz-001","June 27, 2022","July 18, 2022","October 14, 2022","January 26, 2023",,"January 27, 2023","Ankara University, Ankara, Turkey",,"https://ClinicalTrials.gov/show/NCT05699798"
78,"NCT05699720","Acute Exacerbation of COPD and Nebulized Magnesium Sulphate",,"Completed","No Results Available","Chronic Obstructive Pulmonary Disease Exacerbation|Magnesium Sulfate","Drug: Nebulized Magnesium Sulphate","In- Hospital Outcome","King Edward Medical University","All","30 Years to 70 Years   (Adult, Older Adult)","Not Applicable","160","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","7372/REG/KEMU2018","January 1, 2019","December 31, 2020","December 31, 2020","January 26, 2023",,"January 26, 2023","Fawad Ahmad Randhawa, Lahore, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05699720"
79,"NCT05699382","Improvement Mental Health Among Physicians by a Mindfulness-training Mobile Application",,"Completed","No Results Available","Stress","Other: practiced mindfulness through the application for 6 weeks","Perceived Stress Scale-PSS|Mental Health Inventory-MHI|Maslach Burnout Inventory - MBI","Rambam Health Care Campus","All","Child, Adult, Older Adult","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","0150-20-RMB","January 1, 2021","January 1, 2022","December 1, 2022","January 26, 2023",,"January 26, 2023","Pediatric rheumatology clinic, Rambam Medical Center, Haifa, Israel",,"https://ClinicalTrials.gov/show/NCT05699382"
80,"NCT05699161","Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson","SVFP1","Completed","No Results Available","Idiopathic Parkinson Disease|Parkinson's Disease and Parkinsonism","Genetic: Adipose-derived stromal vascular fraction cells","Incidence of treatment related adverse events|L-dopa medication|Minimal clinically important differences (MCIDs)-1|Minimal clinically important differences (MCIDs)-2","Samuel Vilchez, PhD|Wake Forest University|Ministerio de Salud, Nicaragua|GID BIO, Inc.|National Autonomous University of Nicaragua","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 1|Phase 2","10","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Nica-Parkinson-2021","October 14, 2021","October 31, 2022","October 31, 2022","January 26, 2023",,"January 26, 2023","Hospital Escuela Oscar Danilo Rosales Arguello, León, Leon, Nicaragua",,"https://ClinicalTrials.gov/show/NCT05699161"
81,"NCT05698849","Effect of Amino Acid Addition to a Drink on the Appearance of Ingested Water in Body Fluids",,"Completed","No Results Available","Rate of Water Appearance/Delivery in the Blood Water Balance","Other: Composition of Sports Drink","Time at which drink absorption rate was maximum (tmax)|Maximum absorption of drink (Cmax)|Area under the curve for D2O|Plasma volume|Plasma osmolality|Urine specific gravity|Urine volume","Loughborough University|Entrinsic Beverage Company LLC","All","18 Years to 50 Years   (Adult)","Not Applicable","15","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","LEON3151-2859","August 4, 2021","January 27, 2022","July 11, 2022","January 26, 2023",,"January 26, 2023","Loughborough University, Loughborough, Leicestershire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT05698849"
82,"NCT05698797","Proprioceptive Training vs. Hip Abductor With External Rotator Strengthening in Patients With Patellofemoral Pain",,"Completed","No Results Available","Patellofemoral Pain Syndrome","Other: Hip strengthening exercises|Other: Proprioceptive training|Other: Conventional physical therapy","Kujala Anterior Knee Pain Scale (AKPS)","King Saud University","All","18 Years to 35 Years   (Adult)","Not Applicable","45","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","AWH/EC/03/2021","November 11, 2021","May 6, 2022","June 24, 2022","January 26, 2023",,"January 26, 2023","King Saud University, Riyadh, Saudi Arabia",,"https://ClinicalTrials.gov/show/NCT05698797"
83,"NCT05698667","Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer",,"Completed","No Results Available","Oropharynx Cancer|Oropharynx Neoplasm|Tonsil Cancer|Tonsil Neoplasm|Tonsil Hypertrophy|Tonsil Lymphoma|Base of Tongue Tumor|Base of Tongue Carcinoma","Diagnostic Test: Transoral ultrasound|Diagnostic Test: Transcervical ultrasound","Proportion of patients with oropharynx cancer detected by ultrasound compared to MRI|Greatest tumor diameter compared between ultrasound and MRI.|Proportion of patients without oropharynx cancer detected by ultrasound compared to MRI|Tumor volume compared between ultrasound and MRI","Rigshospitalet, Denmark|The Novo Nordic Foundation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","26","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","Transoral US Feasibility","October 1, 2021","May 1, 2022","May 1, 2022","January 26, 2023",,"February 1, 2023","Department of Otorhinolaryngology, Head & Neck Surgery & Audiology, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT05698667"
84,"NCT05698251","Reducing Uncertainty Distress in Long Term Health Conditions",,"Completed","No Results Available","Rheumatic Diseases","Behavioral: Uncertainty distress model","Changes in daily diary measures|Changes in Patient Health Questionnaire (PHQ9) score|Changes in Generalised Anxiety Disorder (GAD7) score|Changes in Brief Pain Inventory (BPI score)|Changes in scores on Mishels Illness Uncertainty Scale Community version (MUIS-C)|Changes in scores on Intolerance of Uncertainty Scale (IUS)- short form|Changes in scores on Intolerance of Uncertainty Behaviours in Everyday Life Questionnaire (IUBEL)|Changes in scores on International Adjustment Disorder Questionnaire (IADQ)","Newcastle University|Newcastle-upon-Tyne Hospitals NHS Trust|Cumbria, Northumberland Tyne and Wear NHS Foundation Trust","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","6","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RES-21-015|21/ES/0063|293383","March 16, 2022","December 20, 2022","December 20, 2022","January 26, 2023",,"February 3, 2023","Royal Victoria Hospital (RVI), Newcastle, United Kingdom","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/51/NCT05698251/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT05698251"
85,"NCT05698108","Effects Of Instrument Assisted Soft Tissue Mobilization on Pain, Grip Strength and Functional Activity in Patients With Lateral Epicondylitis",,"Completed","No Results Available","Lateral Epicondylitis|Tennis Elbow","Device: Instrument Assisted Soft Tissue Mobilization (IASTM)|Other: Conventional Physical Therapy","Pain (mild to severe)|Grip Strength|Functional Activity","University of Lahore","All","20 Years to 50 Years   (Adult)","Not Applicable","72","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","ULahore Shazal Nazir","March 1, 2022","September 30, 2022","November 1, 2022","January 26, 2023",,"January 26, 2023","Sikander Medical Complex, Gujrānwāla, Pujab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05698108"
86,"NCT05697913","Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation",,"Completed","No Results Available","Multiple Myeloma","Other: Continued treatment adapted to the response","Progression Free Survival|Overall Survival|Proportion of patients with serious adverse effects|Average grade 3 or higher adverse events per patient|Annual incidence of grade 3 or higher adverse effects","Hospital Galdakao-Usansolo","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","66","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MRD-Image neg 01","July 1, 2014","November 30, 2019","December 31, 2022","January 26, 2023",,"January 26, 2023",,,"https://ClinicalTrials.gov/show/NCT05697913"
87,"NCT05697900","Creatine Monohydrate Versus Creatine Hydrochloride on Strength and Body Composition in Elite Team-Sport Athletes","CrM_CrHCl","Completed","No Results Available","Healthy Lifestyle","Dietary Supplement: Creatine Monohydrate|Dietary Supplement: Placebo|Dietary Supplement: Creatine Hydrochloride","Lower-limb muscle power|Neuromuscular strength|Upper-limb muscle strength|Body composition","Dynamical Business and Science Society - DBSS International SAS|INDEPORTES Antioquia|CES University","All","18 Years to 30 Years   (Adult)","Not Applicable","48","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Acta161_N°994","June 1, 2021","February 15, 2022","August 22, 2022","January 26, 2023",,"January 26, 2023","INDEPORTES Antioquia, Medellín, Antioquia, Colombia",,"https://ClinicalTrials.gov/show/NCT05697900"
88,"NCT05697887","Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam",,"Completed","No Results Available","Drug Resistant Epilepsy|Ketogenic Diet|Feasibility|Tolerability|Efficacy|Children","Dietary Supplement: Ketogenic diet","The feasibility of the ketogenic diet|The tolerability of the ketogenic diet at 12 months|The efficacy of the ketogenic diet at 12 months","Number 2 Children's Hospital, Ho Chi Minh City","All","1 Year to 10 Years   (Child)","Not Applicable","45","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CH2HCM","June 1, 2019","October 31, 2021","October 31, 2021","January 26, 2023",,"January 26, 2023","N02 Children's Hospital, Ho Chi Minh city, Ho Chi Minh, Vietnam",,"https://ClinicalTrials.gov/show/NCT05697887"
89,"NCT05697653","Effect of Skin to Skin Contact on Sucking Efficiency of Newborns and Breastfeeding Self Efficacy of Mothers in Cesarean Deliveries",,"Completed","No Results Available","Nurse's Role|Breastfeeding","Behavioral: Skin-to-Skin contact.","The effect of skin-to-skin contact on breastfeeding self efficacy of mothers|The effect of skin-to-skin contact on breastfeeding success of mothers and sucking success of newborns.","Kutahya Health Sciences University","Male","1 Hour to 30 Days   (Child)","Not Applicable","72","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","Nursing123","November 18, 2019","March 13, 2020","May 5, 2021","January 26, 2023",,"January 26, 2023","Kutahya Health Sciences University, Kutahya, Turkey",,"https://ClinicalTrials.gov/show/NCT05697653"
90,"NCT05697354","New Virtual Reality Technologies and Telemedicine for Cognitive Rehabilitation in Alzheimer's Disease","TaskCog-IVN","Completed","No Results Available","Alzheimer Disease","Procedure: Cognitive rehabilitation using interactive tablet|Procedure: Cognitive rehabilitation using smartphone App Medico Amico","Change from Mini Mental State Examination after treatment|Change in Quality of life in Alzheimer's disease after treatment|Change in Geriatric Depression Scale after treatment|Change in Beck Depression Inventory-II after treatment|System Usability Scale after treatment","Ospedale San Raffaele","All","50 Years to 80 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","TaskCog-IVN","August 30, 2021","December 21, 2021","December 21, 2021","January 25, 2023",,"January 25, 2023","Ospedale San Raffaele, Milan, Italy",,"https://ClinicalTrials.gov/show/NCT05697354"
91,"NCT05697341","Ultra Mini Percutaneous Nephrolithotomy VS Stented Extracorporeal Shock Wave Lithotripsy for Stone Management",,"Completed","No Results Available","Renal Stone","Procedure: Ultra-Mini-PCNL|Procedure: Stented SWL","Stone-free status","Ain Shams University","All","18 Years to 60 Years   (Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","YRS0001","March 1, 2021","March 1, 2022","June 1, 2022","January 25, 2023",,"January 25, 2023","Ain Shams University, Faculty of medicine, Cairo, Abbassia, Egypt",,"https://ClinicalTrials.gov/show/NCT05697341"
92,"NCT05697315","Erector Spinae Plane Block for Postoperative Pain Management",,"Completed","No Results Available","Pain|Post Operative Pain","Procedure: Control|Procedure: Erector spinae plane block","24-hour opioid consumption|Visual Analog Scale (Vas)","Kahramanmaras Sutcu Imam University","Female","18 Years to 45 Years   (Adult)","Not Applicable","56","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2021-02-03","December 1, 2021","April 1, 2022","April 1, 2022","January 25, 2023",,"January 25, 2023","Kahramanmaras Sutcu Imam University, Kahramanmaraş, Turkey",,"https://ClinicalTrials.gov/show/NCT05697315"
93,"NCT05696951","Tranexamic Acid in Sleeve Gastrectomy",,"Completed","No Results Available","Tranexamic Acid Adverse Reaction","Other: Transamine 200mg iv","effect on bleeding in the first one hours postoperatively|effect on bleeding in the first 24 hours postoperatively","Goztepe Prof Dr Suleyman Yalcın City Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","Bnk723","January 1, 2022","January 1, 2023","January 2, 2023","January 25, 2023",,"January 25, 2023","Göztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadıköy, İstanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT05696951"
94,"NCT05696886","The Effect of Intraoperative Tramadol on Postoperative Opioid","LSG","Completed","No Results Available","Postoperative Pain","Drug: Pethidine|Drug: Tramadol with pethidine","VAS of pain|opioid requirement|hospital stay","Mansoura University","All","16 Years to 65 Years   (Child, Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","R.23.01.2008","January 1, 2021","December 31, 2022","December 31, 2022","January 25, 2023",,"January 25, 2023","Ayman El Nakeeb, Mansoura, Outside U.S And Canada, Egypt",,"https://ClinicalTrials.gov/show/NCT05696886"
95,"NCT05696509","Influence of Anesthetics on Clinical Outcome in Mitral and Aortic Valve Replacement in Adults",,"Completed","No Results Available","Mitral Valve Insufficiency|Aortic Valve Insufficiency","Drug: Propofol|Drug: Isoflurane|Drug: Sevoflurane","cardiac index|Oxygen consumption|Oxygen delivery","Astana Medical University","All","40 Years to 60 Years   (Adult)","Phase 3","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other","AMU3","January 3, 2020","October 13, 2022","October 16, 2022","January 25, 2023",,"January 25, 2023","Bekzat, Astana, Kazakhstan",,"https://ClinicalTrials.gov/show/NCT05696509"
96,"NCT05696457","Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT",,"Completed","No Results Available","Acute Myeloblastic Leukemia|Hematopoietic Stem Cell Transplantation","Behavioral: Passive music therapy","Change in physical and psychological symptom burden|Anxiety and depression assessed by the Hospital Anxiety and Depression Scale (HADS) score|Quality of life assessed by the Functional Assessment of Cancer Therapy - General (FACT-G) score","Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","All","18 Years and older   (Adult, Older Adult)","Not Applicable","71","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","EC086-20","February 1, 2021","November 21, 2022","November 21, 2022","January 25, 2023",,"January 25, 2023","Instituto Investigacion Sanitaria Fundacion Jimenez Diaz, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT05696457"
97,"NCT05696041","Wrist Stabilizing Exercise Versus Hand Orthotic Intervention for Persons With Hypermobility",,"Completed","No Results Available","Musculoskeletal Diseases|Joint Instability","Other: Static strength training program or/and Dynamic strength training program of the hand","DASH questionnaire|The EuroQol EQ-5D|The Jamar dynamometer|The Grip Ability Test","Göteborg University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","169","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","Gothenburg University","August 1, 2014","December 31, 2014","January 31, 2016","January 25, 2023",,"January 25, 2023","Gothenburg University, Gothenburg, Sweden",,"https://ClinicalTrials.gov/show/NCT05696041"
98,"NCT05695664","Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery",,"Completed","No Results Available","Intravenous Drug Usage|Ibuprofen|Ketorolac|Knee Arthroscopy|Postoperative Pain","Drug: Ibuprofen 800 mg|Drug: Ketorolac Injection","Postoperative pain|Rescue analgesia requirement","Benazir Bhutto Hospital, Rawalpindi|Combined Military Hospital, Pakistan","All","40 Years to 80 Years   (Adult, Older Adult)","Early Phase 1","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","156/05/21","August 1, 2021","January 31, 2022","January 31, 2022","January 25, 2023",,"January 25, 2023","Fazal Hussain, Bhakkar, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05695664"
99,"NCT05695625","The Effect of Bilateral Erector Spina Plane Block on Postoperative Analgesia in Cesarean Section Under SpinalAnaesthesia",,"Completed","No Results Available","Pain, Postoperative","Other: Spinal anesthesia + bilateral erector spine plane block|Other: Spinal anesthesia","Postoperative pain|Postoperative analgesic drug consumption|Need for rescue analgesic|Number of patients with postoperative nausea-vomiting and need of antiemetic usage|Patients' satisfaction|First analgesic using time, first mobilization time, hospitalization time|ESPB spread level","Ankara University|Ahmet Onat Bermede|Süheyla Karadağ Erkoç|Volkan Baytaş|Bulut Varlı|Hanife Asuman Uysalel","Female","18 Years to 45 Years   (Adult)","Not Applicable","116","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","AnkaraU-CS-ESPB","May 1, 2020","June 6, 2021","February 1, 2022","January 25, 2023",,"January 25, 2023","Bengi Şafak, Ankara, Turkey",,"https://ClinicalTrials.gov/show/NCT05695625"
100,"NCT05695287","The Effects of Sevoflurane, Isoflurane and Propofol During Cardiac Surgery",,"Completed","No Results Available","Coronary Artery Disease|Mitral Valve Insufficiency|Aortic Valve Insufficiency","Drug: Propofol|Drug: Isoflurane|Drug: Sevoflurane","cardiac index|Oxygen consumption|Oxygen delivery|cardiac stroke","Astana Medical University","All","40 Years to 60 Years   (Adult)","Phase 1","89","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other","10","January 22, 2021","November 19, 2022","December 16, 2022","January 25, 2023",,"January 25, 2023","Bekzat, Astana, Kazakhstan",,"https://ClinicalTrials.gov/show/NCT05695287"
